English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Ferring Pharmaceuticals
Robert Hadley
| Jul 12, 2017
Ferring Pharmaceuticals presents data on Rekovelle fertility drug
Gene Johnson
| Apr 10, 2017
Ferring Pharmaceuticals acquires non-U.S. rights, assets of erectile dysfunction cream
Kyle Perrotti
| Mar 21, 2017
Ferring Pharmaceuticals to work with Brazilian organization to develop anal fissure treatment
Gene Johnson
| Mar 9, 2017
Ferring, Foresee Pharmaceuticals enter exclusive development deal
Keri Carbaugh
| Feb 9, 2017
Ferring, Enteris ink deal to develop oral peptide formula
Keri Carbaugh
| Dec 27, 2016
E.U. grants approval for REKOVELLE by Ferring
Michael Gardiner
| Sep 20, 2015
Ferring Pharmaceuticals to host Phase 2b/3 trials of Selepressin
Trending
+
Pharmaceuticals
Patient Daily
| Jun 2, 2025
PathAI collaborates with Northwestern Medicine on digital pathology advancements
+
Pharmaceuticals
Patient Daily
| May 28, 2025
University of California medical researcher: ‘The 340B program is not associated with an improvement in mortality for low-income patients'
+
Pharmaceuticals
Patient Daily
| May 29, 2025
Executive director of COA on 340B reform: ‘Start with PBMs then mega hospitals that pocket 340B discounts’
+
Regulatory
Patient Daily
| May 30, 2025
Alliance for Pharmacy Compounding calls for eliminating redundant, unauthorized, or ineffective regulation
